Target intelligence / Profile preview

Insulin gene (INS)

Target
INS
Molecular classification
Gene, Hormone precursor gene, Other
01

Overview

The insulin gene (INS) is a small, protein-coding gene spanning approximately 1,425 base pairs on human chromosome 11. It comprises three exons, two introns, and encodes a 110-amino acid preproinsulin precursor protein that is processed to mature insulin in pancreatic beta cells. The insulin protein is a peptide hormone responsible for regulating glucose, fat, and protein metabolism by promoting glucose uptake into cells. Dominant mutations in the insulin gene can cause neonatal-onset diabetes due to toxic misfolding of proinsulin. While the gene itself is not a direct therapeutic target, its mutations serve as diagnostic biomarkers in select forms of diabetes.

Other names
INS geneInsulin locusInsulin polypeptide gene
02

Biological functions

Encodes preproinsulin/proinsulin/insulin precursorRegulation of hormone synthesisOther
03

Disease associations

Monogenic diabetes (e.g., permanent neonatal-onset diabetes caused by dominant mutations in the insulin gene)Other genetic forms of diabetes mellitusOther pancreatic beta-cell dysfunction syndromes
04

Safety considerations

Gene therapy safety (if attempted to target mutations)Misdiagnosis from genetic variants in INS gene
05

Biomarkers

INS gene mutations can be biomarkers for monogenic diabetes or neonatal diabetesGene expression levels in research studies for diabetes risk

Beyond the preview

Go deeper on Insulin gene (INS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin gene (INS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call